Casa Sollievo della Sofferenza

Futó vizsgálatok

• Még nem toboroz

  Sequence Strategy of Immuneoncology (IO-IO) vs IO-tyrosine kinase inhibitors (TKI) followed by TKI in metastatic renal cell carcinoma (mRCC): A randomized phase 3 study Meet uro and FICOG trial. COMBO-Seq trial.

  2025-523903-31-00· 3. fázis· Fondazione IRCCS Istituto Nazionale Dei Tumori· Forrás

• Még nem toboroz

  DYNAMIC ” IDentifY the best therapeutic sequeNcing strAtegy in oncogene addICted NSCLC:” “A multi-arms prospective, randomized phase II study to evaluate the best sequential therapeutic strategis in patients with metastatic non-small cell lung cancer harboring targetable genomic driver alterations”

  2026-525268-16-00· 2/3. fázis· Universita' Degli Studi Di Torino· Forrás

• Toboroz

  A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tumour location (right-PTL) - ARIEL-ENGIC 04 EU trial

  2025-521209-42-00· 4. fázis· Fondazione GONO G.I.· Forrás

• Toboroz

  International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

  NCT07476729· 3. fázis· Charite University, Berlin, Germany· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· AstraZeneca· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

  NCT07673887· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma

  NCT07256158· 3. fázis· Fondazione Italiana Linfomi - ETS· Forrás

• Toboroz

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· 3. fázis· Prilenia· Forrás

• Toboroz

  A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)

  2025-521587-35-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Toboroz

  A phase 2, multicentric study to assess the efficacy and safety of maribavir treatment in hematopoietic stem cell transplant (HSCT) recipients with cytomegalovirus (CMV) infection with a medical condition that contraindicate the administration of ganciclovir, valganciclovir or foscarnet and in those who discontinued first line preemptive therapy with ganciclovir, valganciclovir or foscarnet due to toxicity or intolerance.

  2025-521074-34-00· 2. fázis· Gruppo Italiano Per Il Trapianto Di Midollo Osseo Cellule Staminali Emopoietiche E Terapia Cellulare· Forrás

• Még nem toboroz

  Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies

  NCT07503366· Società Italiana di Endocrinologia e Diabetologia Pediatrica· Forrás

• Toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"

  NCT07381764· 2. fázis· Gruppo Oncologico Italia Meridionale· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  NCT07284849· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  NCT07223814· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Toboroz

  A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

  NCT07595653· argenx· Forrás

• Toboroz

  A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07284758· 2. fázis· C4 Therapeutics, Inc.· Forrás

• Toboroz

  A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07258511· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Phase II randomized trial of XELOX plus DoSTARlimab versus XELOX alone as Consolidation Treatment after Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients – IMMUNOSTAR Trial  -  GOIRC-02-2024

  2024-519798-20-00· 2. fázis· G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica· Forrás

• Toboroz

  A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

  NCT07222761· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.

  NCT07330245· AstraZeneca· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

  NCT06932562· 3. fázis· European Myeloma Network B.V.· Forrás

• Toboroz

  Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia

  2025-520982-39-00· 3. fázis· Universita Degli Studi Di Milano Bicocca· Forrás

• Toboroz

  STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer

  NCT07213570· 2. fázis· National Cancer Institute, Naples· Forrás

• Toboroz

  Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy.

  2025-521640-38-00· 3. fázis· Praxis Precision Medicines Inc.· Forrás

• Fut, nem toboroz

  A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  NCT07091630· 3. fázis· argenx· Forrás

• Toboroz

  A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  NCT07071519· 3. fázis· AbbVie· Forrás

• Toboroz

  CAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected metastatic colorectal cancer patients

  2024-519322-20-00· 3. fázis· Gruppo Oncologico Dell'Italia Meridionale· Forrás

• Toboroz

  CLINICAL AND HUMORAL IMPACT OF PRIMARY TUMOR ABLATION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH IMMUNOTHERAPY.THE ITALIC-RCC RANDOMIZED STUDY

  2024-517789-41-00· 4. fázis· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Forrás

• Toboroz

  Trial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab in First-line Metastatic HER2-positive Gastric or GEJ Cancer

  2024-513122-27-00· 3. fázis· Daiichi Sankyo Inc.· Forrás

• Toboroz

  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  NCT06852222· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  NCT06697301· 2/3. fázis· Eikon Therapeutics· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Efficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures

  2024-514499-42-00· 3. fázis· Neuraxpharm Pharmaceuticals S.L.· Forrás

• Toboroz

  IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

  NCT06713837· 3. fázis· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Forrás

• Toboroz

  An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis

  2023-507853-13-00· 2. fázis· Eli Lilly & Co.· Forrás

• Toboroz

  Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

  2022-502352-31-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  Genetic and Immunity in Heart Failure

  NCT06758128· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Forrás

• Toboroz

  A phase II randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy in pre-treated RAS/BRAF wild type metastatic colorectal cancer patients

  NCT05291156· 2. fázis· Gruppo Oncologico Dell'Italia Meridionale· Forrás

• Toboroz

  A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

  NCT06227910· 3. fázis· Takeda· Forrás

• Toboroz

  A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  2024-512895-36-00· 3. fázis· Akero Therapeutics Inc.· Forrás

• Toboroz

  A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

  NCT06532006· 3. fázis· Shanghai Henlius Biotech· Forrás

• Fut, nem toboroz

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

  NCT06733038· 3. fázis· Gruppo Oncologico del Nord-Ovest· Forrás

• Toboroz

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  NCT06456593· 2. fázis· Abivax S.A.· Forrás

• Toboroz

  A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  NCT06663332· 3. fázis· Janssen Research & Development, LLC· Forrás

Showing 50 of 118.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák14 toboroz
• Crohn-betegség7 toboroz
• Mielóma multiplex6 toboroz
• Gyermekkori daganatok5 toboroz
• Akut mieloid leukémia (AML)4 toboroz
• Zsírmáj (MASLD/MASH)4 toboroz
• Colitis ulcerosa3 toboroz
• Gyomor- és nyelőcsőrák3 toboroz
• Primer biliáris cholangitis (PBC)3 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Amiotrófiás laterálszklerózis (ALS)2 toboroz
• Huntington-kór2 toboroz
• Vesedaganat2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Arthritis psoriatica1 toboroz
• Cytomegalovirus infection1 toboroz
• Epilepszia1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hodgkin-limfóma1 toboroz
• IgA-nefropátia1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus vesebetegség1 toboroz
• Liver cirrhosis1 toboroz
• Lupus (SLE)1 toboroz
• Melanóma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Myasthenia gravis1 toboroz
• Neuroblasztóma1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pikkelysömör1 toboroz
• Prosztatarák1 toboroz
• Szarkóma1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures

  2025-524038-24-00· 3. fázis· Praxis Precision Medicines Inc.· Forrás

• Lezárult

  A study to compare the effect of AVT16 and Entyvio® in subjects with moderate to severe active ulcerative colitis.

  2023-507705-34-00· 3. fázis· Alvotech Swiss AG· Forrás

• Fut, nem toboroz

  A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

  NCT06614192· 2. fázis· AbbVie· Forrás

• Lezárult

  Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis

  2023-508679-34-00· 2. fázis· Anaptysbio Inc.· Forrás

• Lezárult

  Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC

  NCT06578559· 2. fázis· Gruppo Oncologico del Nord-Ovest· Forrás

• Lezárult

  Single arm phase II study of ctDNA-guided encorafenib plus cetuximab retreatment in patients with BRAF V600E mutated mCRC. BRICKET study

  2023-509088-26-00· 2. fázis· Fondazione GONO G.I.· Forrás

• Lezárult

  A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)

  NCT06269107· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)

  NCT06092554· University of Bari· Forrás

• Lezárult

  Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants with Moderate to Severe Ulcerative Colitis

  2022-503005-38-00· 2. fázis· Landos Biopharma Inc.· Forrás

• Lezárult

  A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06049017· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

  2022-502267-37-00· 1/2. fázis· K-Group Beta Inc.· Forrás

• Lezárult

  A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)

  NCT05330429· 2. fázis· Gilead Sciences Inc.· Forrás

• Leállították

  ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

  NCT05743036· 1. fázis· K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc· Forrás

• Lezárult

  Phase 2b Study of GSK4532990 in Adults With NASH

  NCT05583344· 2. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

  NCT05611671· 2. fázis· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Forrás

• Lezárult

  ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

  NCT05507203· 3. fázis· Abivax S.A.· Forrás

• Lezárult

  A Study in Participants With Non-cirrhotic NASH With Fibrosis

  NCT05638737· 2. fázis· AstraZeneca· Forrás

• Toboroz

  Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

  NCT05254171· 2/3. fázis· Panbela Therapeutics, Inc.· Forrás

• Lezárult

  A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

  NCT05254002· 2. fázis· Bayer· Forrás

• Lezárult

  A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

  NCT05358717· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Big Data for Quality of Life in Head and Neck Cancer

  NCT05315570· Fondazione IRCCS Istituto Nazionale dei Tumori, Milano· Forrás

• Lezárult

  An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Patients with Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas (NAVAL-1)

  2024-512717-41-00· 2. fázis· Viracta Therapeutics Inc.· Forrás

• Lezárult

  A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease

  2024-513569-38-00· 2/3. fázis· Arena Pharmaceuticals Inc.· Forrás

• Lezárult

  The aim of the study is to evaluate the efficacy of Ponatinib, either alone or in combination with chemotherapy, in inducing remission in patients: MRD positive (persistent or relapsed), patients after haematological and extra-haematological relapse and patients who do not have never achieved remission after any previous treatment.

  NCT04475731· 2. fázis· Fondazione Gimema Franco Mandelli Onlus· Forrás

• Toboroz

  Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

  NCT04442412· 3. fázis· Fondazione Italiana Linfomi - ETS· Forrás

• Lezárult

  Comparison of two strategies that use the same drugs but with inverted sequence for the treatment of patients with metastatic colorectal cancer who have failed in previous therapies.

  2024-513296-41-00· 2. fázis· Fondazione GONO G.I.· Forrás

• Fut, nem toboroz

  Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT04384484· 3. fázis· ADC Therapeutics S.A.· Forrás

• Lezárult

  Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients

  NCT04072198· 2. fázis· Gruppo Oncologico Italiano di Ricerca Clinica· Forrás

• Fut, nem toboroz

  A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03596645· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Sequential Combo Immuno and Target Therapy (SECOMBIT) Study

  NCT02631447· 2. fázis· Fondazione Melanoma Onlus· Forrás

• Lezárult

  autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European MCL Network trial

  2024-511235-10-00· 3. fázis· Klinikum der Universitaet Muenchen AöR· Forrás

• Lezárult

  New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

  NCT02329080· 2. fázis· International Extranodal Lymphoma Study Group (IELSG)· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Huntington-kór16 munka · 4 vizsgálat
• Myasthenia gravis6 munka · 2 vizsgálat